- Home
- CRC vs AXSM Comparison
CRC vs AXSM Comparison
Compare CRC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRC | AXSM |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 7.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRC | AXSM |
|---|---|---|
| Price | $43.67 | $154.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 20 |
| Target Price | $63.70 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 946.3K | 479.4K |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | ★ 3.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.29 | N/A |
| Revenue | ★ $3,505,000,000.00 | $561,263,000.00 |
| Revenue This Year | $20.33 | $66.20 |
| Revenue Next Year | N/A | $57.56 |
| P/E Ratio | $10.16 | ★ N/A |
| Revenue Growth | 34.91 | ★ 65.83 |
| 52 Week Low | $30.97 | $75.56 |
| 52 Week High | $58.41 | $154.49 |
Technical Indicators
Market Signals| Indicator | CRC | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 32.48 | 64.90 |
| Support Level | $44.45 | $145.07 |
| Resistance Level | $45.87 | $149.13 |
| Average True Range (ATR) | 1.34 | 4.21 |
| MACD | -0.38 | -0.04 |
| Stochastic Oscillator | 1.74 | 86.52 |
Price Performance
Historical ComparisonAbout CRC California Resources Corporation
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.